BioCryst Pharmaceuticals, Inc. held its Annual Meeting of Stockholders and approved the amendment and restatement of the Stock Incentive Plan, increasing the number of shares available for issuance by 7,000,000 shares.
AI Assistant
BIOCRYST PHARMACEUTICALS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.